Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Zhang, L
Title
High-Throughput Neurite Outgrowth Assay Using GFP-Labeled iPSC-Derived Neurons.
Citation
Current protocols; 2022 Sep; 2(9) pge542
PubMed ID
36102902
Show Usages
Product Cited
Cross-Reactivity
Applications
450-02
Human
in vitro
450-10
Human
in vitro
100-21C
Human
in vitro
First Author
Noda, K
Title
Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis
Citation
Scientific reports; 2021 Sep 15; 11(1) pg18399
PubMed ID
34526577
Show Usages
Product Cited
Cross-Reactivity
Applications
100-46
Human
in vitro
300-01A
Human
in vitro
200-01B
Human
in vitro
100-21C
Human
in vitro
First Author
Do Pham, D D
Title
Novel lipophosphonoxin-loaded polycaprolactone electrospun nanofiber dressing reduces Staphylococcus aureus induced wound infection in mice
Citation
Scientific reports; 2021 Sep 3; 11(1) pg17688
PubMed ID
34480072
Show Usages
Product Cited
Cross-Reactivity
Applications
100-21C
Human
in vitro
100-21C
Human
Chemotaxis Assay
100-21C
Human
Immunostaining
First Author
Bassil, R
Title
Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia
Citation
Nature communications; 2021 Sep 1; 12(1) pg5220
PubMed ID
34471104
Show Usages
Product Cited
Cross-Reactivity
Applications
450-02
Human
in vitro
450-10
Human
in vitro
200-34
Human
in vitro
300-25
Human
in vitro
100-18B
Human
in vitro
AF-100-15
Human
in vitro
100-21C
Human
in vitro
First Author
Steinberg, D J
Title
Modeling genetic epileptic encephalopathies using brain organoids.
Citation
EMBO molecular medicine; 2021 Aug 9; 13(8) pge13610
PubMed ID
34268881
Show Usages
Product Cited
Cross-Reactivity
Applications
100-18B
Human
in vitro
300-07
Human
in vitro
200-03
Human
in vitro
200-06
Human
in vitro
450-02
Human
in vitro
450-10
Human
in vitro
100-21C
Human
in vitro
First Author
Chen, L
Title
Pretreatment with valproic acid alleviates pulmonary fibrosis through epithelial-mesenchymal transition inhibition in vitro and in vivo
Citation
Laboratory investigation; a journal of technical methods and pathology; 2021 Sep; 101(9) pg1166-1175
PubMed ID
34168289
Show Usages
Product Cited
Cross-Reactivity
Applications
100-21C
Human
in vitro
First Author
Lee, Y J
Title
Proinflammatory Features of Stem Cell-like Memory T Cells from Human Patients with Rheumatoid Arthritis.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2021 Jul 15; 207(2) pg381-388
PubMed ID
34162725
Show Usages
Product Cited
Cross-Reactivity
Applications
200-02
Human
in vitro
200-04
Human
in vitro
200-01B
Human
in vitro
200-06
Human
in vitro
100-21C
Human
in vitro
First Author
Warita, K
Title
Concomitant attenuation of HMGCR expression and activity enhances the growth inhibitory effect of atorvastatin on TGF-β-treated epithelial cancer cells
Citation
Scientific reports; 2021 Jun 17; 11(1) pg12763
PubMed ID
34140545
Show Usages
Product Cited
Cross-Reactivity
Applications
100-21C
Human
in vitro
First Author
Gonzalez, M M
Title
BMI1 maintains the Treg epigenomic landscape to prevent inflammatory bowel disease.
Citation
The Journal of clinical investigation; 2021 Jun 15; 131(12)
PubMed ID
34128475
Show Usages
Product Cited
Cross-Reactivity
Applications
200-02
Human
in vitro
100-21C
Human
in vitro
First Author
Chen, Y
Title
Pre-emptive pharmacological inhibition of fatty acid-binding protein 4 attenuates kidney fibrosis by reprogramming tubular lipid metabolism.
Citation
Cell death & disease; 2021 Jun 3; 12(6) pg572
PubMed ID
34083513
Show Usages
Product Cited
Cross-Reactivity
Applications
100-21C
Human
in vitro
showing 10 of 158
Show More